Abstract Search

ea0011p32 | Bone | ECE2006

Baseline characteristics of postmenopausal Greek women with osteoporosis who had inadequate clinical response to antiresorptive medications.

Ginis A , Charalampidou E , Thalassinos N , the Hellenic OSSO Study Group N

Aims: The Observational Study of Severe Osteoporosis (OSSO) is a 12-month, European, prospective study aiming to assess the changes in Health Related Quality of Life (HRQoL) of women with osteoporosis (OP) and an inadequate clinical response to antiresorptive (AR) medications.Methods: In Greece, 263 of 271 (97%) patients (pts) with severe OP met the inclusion criteria. The study population was assigned to1of 2 groups according to one or more of the follo...

0 shares

ea0056p92 | Clinical case reports - Pituitary/Adrenal | ECE2018

Severe pheochromocytoma crisis, Type B, resulting in Takotsubo-like cardiomyopathy and fulminant refractory cardiogenic shock, successfully treated with extracorporeal membrane oxygenation (ECMO) but with fatal neurological sequelae for the patient.

Tyfoxylou Ernestini , Kounadi Theodora , Markou Athina , Papanastasiou Labrini , Charalampidou Liana , Kyriazi Evangelia , Voulgaris Nikolaos , Neoklis Skampas , Pyrgakis Vlassios , Piaditis George

Introduction: Catecholamine excess causes profound vasoconstriction, resulting in reduced intravascular volume. Pheochromocytoma crisis can be further complicated with acute stress (Takotsubo-like) cardiomyopathy, attributed to the toxic catecholamine effect on the myocardium, and cardiogenic shock leading to tissue ischemia.Aim: To present a rare case of pheochromocytoma crisis, complicated with fulminant cardiogenic shock, which led to life-threatening...

0 shares

ea0063ep18 | Adrenal and Neuroendocrine Tumours | ECE2019

Characteristics, management and outcome of patients with adrenocortical carcinoma in a tertiary hospital: a retrospective study

Papanastasiou Labrini , Choreftaki Theodosia , Zografos George , Kapsali Chara , Kalantzi Athanasia , Monastirioti Nikoleta , Gravvanis Christos , Glykofridi Spyridoula , Tyfoxilou Ernestini , Vlaxou Sofia , Charalampidou Liana , Voulgaris Nikos , Markou Athina , Giagourta Irini , Piaditis George , Kounadi Theodora

Adrenocortical carcinoma (ACC) is a rare, aggressive tumor with poor prognosis, affecting 0.52 cases/106population/year.Objective: To analyse retrospectively characteristics, management and outcome of ACC patients, followed in our center between 20102018.Material and methods: The medical records related to diagnosis, treatment and follow-up of nine patients of 59.2±13.8 years with histological diagnosis ...

0 shares

ea0056p20 | Adrenal cortex (to include Cushing's) | ECE2018

Prevalance of primary aldosteronism in hypertensive patients: epidemiological data from a tertiary centre

Voulgaris Nikolaos , Papanastasiou Labrini , Vlachou Sofia , Kyriazi Evangelia , Tyfoxylou Ernestini , Monastirioti Nikoletta , Kapsali Chara , Charalampidou Liana , Aglaia Zachaki , Kalantzi Athanasia , Gravvanis Christos , Markou Athina , Giagourta Eirini , Kounadi Theodora , Kassi Eva , Kaltsas Gregory , Piaditis George

Introduction: Primary aldosteronism (PA) is the most common cause of endocrine hypertension. Its prevalence varies from 5-15%, which depends mainly on the cut-offs of the diagnostic tests.Aim: To estimate the prevalence of PA in patients with different stages of hypertension based on a dynamic overnight diagnostic test.Methods: One hundred ninety nine hypertensive patients were divided in 3 groups according to the stage of hyperten...

0 shares

ea0056p21 | Adrenal cortex (to include Cushing's) | ECE2018

Renin: a possible novel marker for the efficacy of pharmacological treatment of primary aldosteronism

Voulgaris Nikolaos , Vlachou Sofia , Kyriazi Evangelia , Papaoikonomou Eleni , Tyfoxylou Ernestini , Monastirioti Nikoletta , Kapsali Chara , Zachaki Aglaia , Charalampidou Liana , Kounadi Theodora , Markou Athina , Papanastasiou Labrini , Giagourta Eirini , Kassi Eva , Kaltsas Gregory , Piaditis George

Introduction: Primary aldosteronism (PA) treatment is either pharmacological with aldosterone receptor antagonists (MRAs) or surgical with the resection of the responsible adenoma. The efficacy of MRAs treatment is based on the normalization of blood pressure (BP) in relation to potassium levels. However, it remains unclear whether the stimulation of renin levels during treatment could serve as an additional marker of adequate MR blockade.Aim: To investi...

0 shares

Endocrine Abstracts

Baseline characteristics of postmenopausal Greek women with osteoporosis who had inadequate clinical response to antiresorptive medications.

Severe pheochromocytoma crisis, Type B, resulting in Takotsubo-like cardiomyopathy and fulminant refractory cardiogenic shock, successfully treated with extracorporeal membrane oxygenation (ECMO) but with fatal neurological sequelae for the patient.

Characteristics, management and outcome of patients with adrenocortical carcinoma in a tertiary hospital: a retrospective study

Prevalance of primary aldosteronism in hypertensive patients: epidemiological data from a tertiary centre

Renin: a possible novel marker for the efficacy of pharmacological treatment of primary aldosteronism

BiosciAbstracts